EP1261304A1 - Therapies de refroidissement/dispositif pour angioplastie avec restenose - Google Patents

Therapies de refroidissement/dispositif pour angioplastie avec restenose

Info

Publication number
EP1261304A1
EP1261304A1 EP01916337A EP01916337A EP1261304A1 EP 1261304 A1 EP1261304 A1 EP 1261304A1 EP 01916337 A EP01916337 A EP 01916337A EP 01916337 A EP01916337 A EP 01916337A EP 1261304 A1 EP1261304 A1 EP 1261304A1
Authority
EP
European Patent Office
Prior art keywords
balloon
catheter
fluid
warm
cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01916337A
Other languages
German (de)
English (en)
Other versions
EP1261304A4 (fr
Inventor
John D. Dobak, Iii
Hans W. Kramer
Steve A. Yon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innercool Therapies Inc
Original Assignee
Innercool Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innercool Therapies Inc filed Critical Innercool Therapies Inc
Publication of EP1261304A1 publication Critical patent/EP1261304A1/fr
Publication of EP1261304A4 publication Critical patent/EP1261304A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22001—Angioplasty, e.g. PCTA
    • A61B2017/22002—Angioplasty, e.g. PCTA preventing restenosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22054—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation with two balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00023—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022—Balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0212—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument inserted into a body lumen, e.g. catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0231—Characteristics of handpieces or probes
    • A61B2018/0262—Characteristics of handpieces or probes using a circulating cryogenic fluid

Definitions

  • Balloon angioplasty or the technology of reshaping of a blood vessel for the purpose of establishing vessel patency using a balloon tipped catheter, has been known since the late 1970' s.
  • the procedure involves the use of a balloon catheter that is guided by means of a guidewire through a guiding catheter to the target lesion or vessel blockage.
  • the balloon typically is equipped with one or more marker bands that allow the interventionalist to visualize the position of the balloon in reference to the lesion with the aid of fluoroscopy.
  • the balloon is inflated with a biocompatible fluid, and pressurized to the appropriate pressure to allow the vessel to open.
  • Typical procedures are completed with balloon inflation pressures between 8 and 12 atmospheres.
  • the balloon inflation procedure is repeated several times before the lesion or blockage will yield.
  • the placement of stents after angioplasty has become popular as it reduces the rate of restenosis.
  • Restenosis refers to the renarrowing of the vascular lumen following vascular intervention such as a balloon angioplasty procedure or stent insertion. Restenosis is clinically defined as a greater than 50% loss of initial lumen diameter. The mechanism or root causes of restenosis are still not fully understood. The causes are multifactorial, and are partly the result of the injury caused by the balloon angioplasty procedure and stent placement. With the advent of stents, restenosis rates have dropped from over 30% to 10-20%. Recently, the use and effectiveness of low-dose radiation administered intravascularly following angioplasty is being evaluated as a method to alter the DNA or RNA of an affected vessel's cells in the hope of reducing cell proliferation.
  • Atrial fibrillation refers to very rapid irregular contractions of the atria of the heart resulting in a lack of synchronization between the heartbeat and the pulse. The irregular contractions are due to irregular electrical activity that originates in the area of the pulmonary veins.
  • a proposed device, currently under development, for treating atrial fibrillation is a balloon filled with saline that can be ultrasonically agitated and heated. This device is inserted in the femoral vein and snaked into the right atrium. The device is then poked through the interatrial septum and into the left atrium, where it is then angled into the volume adjoining the suspect pulmonary vein with the left atrium.
  • tissues can only safely be heated to temperatures of less than or about 75°C - 85°C due to charring and tissue rupture secondary to steam formation.
  • the thermal gradient thus induced is fairly minimal, leading to a limited heat transfer.
  • heating causes tissues to become less adherent to the adjacent heat transfer element, the tissue contact with the heat transfer element is also reduced, further decreasing the heat transfer.
  • the present invention provides an enhanced method and device to inhibit or reduce the rate of restenosis following angioplasty or stent placement.
  • the invention is similar to placing an ice pack on a sore or overstrained muscle for a period of time to minimize or inhibit the bio-chemical events responsible for an associated inflammatory response.
  • An embodiment of the invention generally involves placing a balloon-tipped catheter in the area treated or opened through balloon angioplasty immediately following angioplasty.
  • a so- called "cryoplasty" balloon which can have a dual balloon structure, may be delivered through a guiding catheter and over a guidewire already in place from a balloon angioplasty.
  • the dual balloon structure has benefits described below and also allows for a more robust design, providing significant safety advantages to the patient because two balloons must be broken if cooling fluid is to deleteriously infuse into the patient .
  • the dual balloon may be centered in the recently opened vessel with the aid of radio opaque marker bands, indicating the "working length" of the balloon. In choosing a working length, it is important to note that typical lesions may have a size on the order of 2-3 cm.
  • a biocompatible heat transfer fluid which may contain contrast media, may be infused through the space between the dual balloons. While this fluid does not circulate in this embodiment, once it is chilled or even frozen by thermal contact with a cooling fluid, it will stay sufficiently cold for therapeutic purposes.
  • a biocompatible cooling fluid with a temperature between about, e.g., - 40°C and -60°C, may be injected into the interior of the inner balloon, and circulated through a supply lumen and a return lumen.
  • the fluid exits the supply lumen through a skive in the lumen, and returns to the refrigeration unit via another skive and the return lumen.
  • the biocompatible cooling fluid chills the biocompatible heat transfer fluid between the dual balloons to a therapeutic temperature between about, e.g., 0°C and -50°C.
  • the chilled heat transfer fluid between the dual balloons transfers thermal energy through the balloon wall and into the adjacent intimal vascular tissue for the appropriate therapeutic length of time.
  • the circulation of the biocompatible cooling fluid is stopped, and the heat transfer fluid between the dual balloons withdrawn through the annular space. Both balloons may be collapsed by means of causing a soft vacuum in the lumens. Once collapsed, the cryoplasty catheter may be withdrawn from the treated site and patient through the guiding catheter.
  • the invention is directed to a device to treat tissue, including an outer tube, an an inner tube disposed at least partially within the outer tube, and a dual balloon including an inner balloon and an outer balloon, the inner balloon coupled to the inner tube at a proximal and at a distal end, the outer balloon coupled to the inner tube at a distal end and to the outer tube at a proximal end.
  • a first interior volume is defined between the outer balloon and the inner balloon in fluid communication with an inlet in the volume between the outer tube and the inner tube .
  • Variations of the invention may include one or more of the following.
  • the inner tube may further define a guidewire lumen, a supply lumen, and return lumen.
  • the supply lumen may define a hole or skive such that a fluid flowing in the supply lumen may be caused to flow into a volume defined by the inner balloon
  • the return lumen may define a hole or skive such that a fluid flowing in a volume defined by the inner balloon may be caused to flow into the return lumen.
  • the guidewire lumen may extend from a proximal end of the inner tube to a distal end of the inner tube.
  • the device may further comprise at least two radially extending tabs disposed around a circumference of the inner tube to substantially center the inner tube within the dual balloon.
  • the device may further comprise at least one marker band disposed on the inner tube to locate a working region of the device at a desired location.
  • the device may further comprise a source of chilled fluid having a supply tube and a return tube, the supply tube coupled in fluid communication to the supply lumen and the return tube coupled in fluid communication to the return lumen.
  • a source of fluid may also be included, the source of fluid coupled in fluid communication to a volume between the inner balloon and the outer balloon.
  • the fluid may be a perfluorocarbon such as Galden fluid.
  • the fluid may also include contrast media.
  • the invention is directed to a method of reducing restenosis after angioplasty in a blood vessel .
  • the method includes inserting a catheter into a blood vessel, the catheter having a balloon.
  • the balloon is then inflated with a perfluorocarbon such that an exterior surface of the balloon is in contact with at least a partial inner perimeter of the blood vessel, the perfluorocarbon having a temperature in the range of about -10°C to -50°C.
  • Variations of the method may include one or more of the following.
  • the method may include disposing the catheter at a desired location using at least one radio opaque marker band.
  • the method may include flowing the perfluorocarbon into the balloon using a supply lumen and exhausting the perfluorocarbon from the balloon using a return lumen.
  • the balloon may be a dual balloon, and the method may further include providing a heat transfer fluid in the volume between the dual balloons.
  • the heat transfer fluid may include a contrast media fluid.
  • the method may include disposing the catheter such that at least a portion of the balloon is in a coronary artery or in a carotid artery.
  • the invention is directed to a method of reducing atrial fibrillation.
  • the method includes inserting a catheter at least partially into the heart, the catheter having a balloon, a portion of the balloon located in the left atrium and a portion of the balloon located in a pulmonary vein.
  • the balloon is then inflated with a perfluorocarbon such that an exterior surface of the balloon is in contact with at least a partial circumference of the portion of the pulmonary vein adjacent the left atrium, the perfluorocarbon having a temperature in the range of about -10°C to -50°C.
  • Variations of the method may include one or more of the following.
  • the balloon may have a working region having a length of between about 5 mm and 10 mm.
  • the method may further include inserting a wire having a needle point from the femoral vein into the right atrium and forming a hole using the needle point in the interatrial septum between the right atrium and the left atrium.
  • a guide catheter may then be inserted into the right atrium.
  • a guide wire may further be inserted through the guide catheter into the right atrium and further into a pulmonary vein.
  • the catheter may then be disposed over the guidewire into a volume defined by the joint of the right atrium and the pulmonary vein.
  • the invention inhibits or reduces the rate of restenosis following a balloon angioplasty or any other type of vascular intervention. At least the following portions of the vascular anatomy can benefit from such a procedure: the abdominal aorta (following a stent or graft placement) , the coronary arteries (following PTCA or rotational artherectomy) , the carotid arteries (following an angioplasty or stent placement) , as well as the larger peripheral arteries.
  • FIG. 1A shows a side schematic view of a catheter according to a first embodiment of the invention.
  • FIG. IB shows a cross- sectional view of the catheter of FIG. 1A, as indicated by lines IB- IB in FIG. 1A.
  • FIG. 1C shows an alternate cross-sectional view of the catheter of FIG. 1A, as indicated by lines IB-IB in FIG. 1A.
  • FIG. 2A shows a side schematic view of a catheter according to a second embodiment of the invention.
  • FIG. 2B shows a cross-sectional view of the catheter of FIG. 2A, as indicated by lines 2B-2B in FIG. 2A.
  • FIG. 3 shows a schematic view of a catheter in use according to a third embodiment of the invention.
  • FIG. 4 shows a cross-sectional view of the catheter of FIG. 3.
  • FIG. 5 shows an alternative cross -sectional view of the catheter of FIG. 3.
  • FIG. 6 shows an alternative cross-sectional view of the catheter of FIG. 3.
  • FIG. 7 shows a schematic view of the warm balloon of the catheter of FIG. 3.
  • a catheter 100 is shown according to a first embodiment of the invention.
  • the catheter 100 has a proximal end 130 and a distal end 114.
  • this figure is not necessarily to scale and in general use the proximal end 130 is far upstream of the features shown in FIG. 1A.
  • the catheter 100 may be used within a guide catheter 102, and generally includes an outer tube 103, a dual balloon 134, and an inner tube 122. These parts will be discussed in turn.
  • the guide catheter 102 provides a tool to dispose the catheter 100 adjacent the desired location for, e.g., angioplasty or reduction of atrial fibrillation.
  • Typical guide catheter diameters may be about 6 french to 9 french, and the same may be made of polyether blockamide, polyamides, polyurethanes, and other similar materials.
  • the distal end of the guide catheter is generally adjacent the proximal end of the dual balloon 134, and further is generally adjacent the distal end of the outer tube 103.
  • the ability to place the guide catheter is a significant factor in the size of the device.
  • a suitably sized guide catheter must be used. This restricts the size of the catheter 100 that may be disposed within the guide catheter. A typical diameter of the catheter 100 may then be about 7 french or less or about 65 to 91 mils.
  • a catheter for use in the coronary arteries is described. Of course, which catheter is used in which artery is a matter to be determined by the physician, taking into account such factors as the size of the individual patient's affected arteries, etc.
  • the outer tube 103 houses the catheter 100 while the latter traverses the length of the guide catheter 102.
  • the outer tube 103 may have a diameter of about 4 french to 7 french, and the same may be made of polyether blockamide, poly-butylene terephtalate, polyurethane, polyamide, polyacetal polysulfone, polyethylene, ethylene tetrafluoroethylene, and other similar materials.
  • the distal end of the outer tube 103 adjoins the proximal end of the dual balloon 134.
  • the outer tube 103 provides a convenient location for mounting a proximal end of an outer balloon 104 within the dual balloon 134, and further may provide an inlet 128 for providing a fluid such as a liquid to a first interior volume 106 between the dual balloons.
  • a fluid such as a liquid to a first interior volume 106 between the dual balloons.
  • an inlet 128 per se may not be necessary: the fluid, which may also be a sub-atmospheric level of gas or air, may be provided during manufacture in the first interior volume 106.
  • the proximal and distal ends of the first interior volume may be sealed during manufacture.
  • the inlet 128 may be at least partially defined by the annular volume between the interior of the outer tube 103 and the exterior of the inner tube 122.
  • the dual balloon 134 includes an outer balloon 104 and an inner balloon 108. Between the two is the first interior volume 106.
  • the outer balloon 104 may be inflated by inflating the interior volume 106.
  • the inner balloon 108 has a second interior volume 110 associated with the same.
  • the inner balloon 108 may be inflated by inflating the second interior volume 110.
  • both the inner balloon 108 and the outer balloon 104 may be inflated using biocompatible liquids, such as Galden ® fluid, perfluorocarbon-based liquids, or various contrast agents. There is no need that the fluid inflating one of the interior volumes be the same fluid as that inflating the other. Additional details on these fluids are described below.
  • this fluid may be, e.g., stationary or static: in other words, it need not be circulated.
  • this fluid would in general be circulated by an external chiller (not shown) .
  • the chiller may be, e.g., a gear pump, peristaltic pump, etc. It may be preferable to use a gear pump over a peristaltic pump as the attainable pressure of the former is generally greater than that of the latter.
  • gear pumps have the advantageous property of being linear, i.e., their output varies in direction proportion with their revolutions per minute. Two types of gear pumps which may be employed include radial spur gear pumps and helical tooth gear pumps.
  • the helical tooth gear pump may be more preferable as the same has been associated with higher pressures and a more constant output.
  • the ability to achieve high pressures may be important as the cooling fluid is required to pass through a fairly narrow, e.g., five to seven french, catheter at a certain rate.
  • the viscosity of the fluid, at the low temperatures should be appropriately low. In this way, e.g., the flow may be increased.
  • an appropriate type of fluid may be Galden ® fluid, and in particular Galden ® fluid item number "HT-55", available from Ausimont Inc. of Thorofare, NJ. At -55°C, this fluid has a viscosity of 2.1 centiStokes. At -70°C, this fluid has a viscosity of 3.8 centiStokes. It is believed that fluids with such viscosities at these temperatures would be appropriate for use.
  • the so-called “cones” of the balloons 108 and 104 may be made somewhat thicker than the remainder of the balloon sections. In this way, the heat transfer efficiency in these sections is significantly less than over the remainder of the balloon sections, this "remainder” effectively defining a "working region” of the balloon. In this way, the cooling or "cryoplasty" may be efficiently localized to the affected area rather than spread over the length of the balloon.
  • the inner tube 122 is disposed within the interior of the dual balloon 134 and within the interior of the guide catheter 102.
  • the inner tube 122 includes a supply lumen 120, a return lumen 118, and a guidewire lumen 116.
  • the guidewire lumen 116 may have sizes of, e.g., 17 or 21 mils inner diameter, in order to accommodate current standard sized guidewires, such as those having an outer diameter of 14 mils. This structure may be preferable, as the pressure drop encountered may be substantially less.
  • the supply lumen 120 may be used to supply a circulating liquid to the second interior volume 110.
  • the return lumen 118 may be used to exhaust the circulating liquid from the second interior volume to the external chiller. As may be seen from FIG.
  • both lumens 118 and 120 may terminate prior to the distal end 114 of the catheter 100.
  • the lumen arrangement may be seen more clearly in Fig. IB.
  • Fig. 1C shows an alternate such arrangement, and one that may provide an even better design for minimal pressure drop.
  • lumens 118' and 120' are asymmetric about guidewire lumen 116'.
  • a set of radio opaque marker bands 112 may be disposed on the inner tube 122 at locations substantially adjacent the cones 132 to define a central portion of the "working region" of the balloons 104 and 108. This working region is where the "cryoplasty" procedures described below may substantially occur.
  • the proximal portion of the outer balloon 104 is mounted on the outer tube 103 at its distal end.
  • the distal end of the outer balloon 104 is secured to the distal end of the catheter 100 and along the inner tube 122.
  • both the proximal and distal ends of the inner balloon 108 may be secured to the inner tube 122 to create a sealed second interior volume 110.
  • At least two skives 124 and 126 may be defined by the inner tube 122 and employed to allow the working fluid to exit into the second interior volume 110 and to exhaust the same from the second interior volume 10.
  • the skive 124 is in fluid communication with the lumen 120 and the skive 126 is in fluid communication with the lumen 118.
  • fluid communication refers to a relationship between two vessels where a fluid pressure may cause a net amount of fluid to flow from one vessel to the other.
  • the skives may be formed by known techniques .
  • a suitable size for the skives may be from about 50 mils to 125 mils.
  • a plurality of tabs 119 may be employed to roughly or substantially center the inner tube 122 within the catheter 100. These tabs may have the shape shown, the shape of rectangular or triangular solids, or other such shapes so long as the flow of working fluid is not unduly impeded. In this specification, the phrase "the flow of working fluid is not unduly impeded” is essentially equated to the phrase “substantially center” .
  • the tabs 119 may be made of polyether blockamide, poly-butylene terephtalate, polyurethane, polyamide, polyacetal polysulfone, polyethylene, ethylene tetrafluoroethylene, and other similar materials, and may have general dimensions of from about 3 mils to 10 mils in height, and by about 10 mils to 20 mils in width.
  • the guide catheter 102 may be inserted into an affected artery or vein such that the distal tip of the guide catheter is just proximal to an affected area such as a calcified area or lesion.
  • an affected area such as a calcified area or lesion.
  • typical lesions do not occur in the venous system, but only in the arterial .
  • the guide catheter may be placed using a guide wire (not shown) . Both the guide catheter and guide wire may already be in place as it may be presumed a balloon angioplasty or stent placement has previously been performed.
  • the catheter 100 may then be inserted over the guide wire via the lumen 116 and through the guide catheter 102. In general, both a guide wire and a guide catheter are not strictly necessary - one or the other may often suffice.
  • the dual balloon 134 may be uninflated to maintain a minimum profile. In fact, a slight vacuum may be drawn to further decrease the size of the dual balloon 134 so long as the structural integrity of the dual balloon 134 is not thereby compromised.
  • a fine positioning step may occur by way of the radio opaque marker bands 112.
  • the location of the radio opaque marker bands 112 can be identified in relation to the location of the lesion.
  • the catheter may be advantageously placed at the location of the lesion and further such that the lesion is between the two marker bands. In this way, the working region of the balloon 134 will substantially overlap the affected area, i.e., the area of the lesion.
  • a biocompatible heat transfer fluid which may also contain contrast media, may be infused into the first interior volume 106 through the inlet 128. While the use of contrast media is not required, its use may allow early detection of a break in the balloon 104 because the contrast media may be seen via fluoroscopy to flow throughout the patient's vasculature.
  • a biocompatible cooling fluid may be circulated through the supply lumen 120 and the return lumen 118. Before or during the procedure, the temperature of the biocompatible cooling fluid may be lowered to a therapeutic temperature, e.g., between -40°C and -60°C, although the exact temperature required depends on the nature of the affected area.
  • the fluid exits the supply lumen 120 through the skive 124 and returns to the chiller through the skive 126 and via the return lumen 118. It is understood that the respective skive functions may also be reversed without departing from the scope of the invention.
  • Substantially the same catheter may be used to treat atrial fibrillation.
  • the catheter is inflated as above once it is in location.
  • the location chosen for treatment of atrial fibrillation is such that the working region spans a portion of the left atrium and a portion of the affected pulmonary vein.
  • the working region of the catheter may have a length of about 5 mm to 30 mm.
  • the affected pulmonary vein, of the four possible pulmonary veins, which enter the left atrium, may be determined by electrophysiology studies .
  • a catheter with a needle point may first be inserted at the femoral vein and routed up to the right atrium.
  • the needle of the catheter may then be poked through the interatrial septum and into the left atrium.
  • the catheter may then be removed if desired and a guide catheter disposed in the same location.
  • a guide wire may be used through the guide catheter and may be maneuvered at least partially into the pulmonary vein.
  • a catheter such as the catheter 100 may be placed in the volume defining the intersection of the pulmonary vein and the left atrium.
  • a method of use similar to that disclosed above is then employed to cool at least a portion of, and preferably all of, the circumferential tissue.
  • the coldness of the balloon assists in the adherence of the circumferential tissue to the balloon, this feature serving to increase the overall heat transfer rate.
  • the catheter 100 above may be particularly useful for procedures in the carotid arteries by virtue of its size.
  • an even smaller catheter may be desired. For example, one with an outer diameter less than 5 french may be desired.
  • a catheter 200 is shown according to a second embodiment of the invention.
  • the catheter 200 may be particularly useful for use in the coronary arteries because the dimensions of the catheter 200 may be considerably smaller than the dimensions of the catheter 100.
  • the catheter 200 is similar to the above-described catheter 100.
  • the catheter 200 has a proximal end 230 and a distal end 214 and may be used within a guide catheter 202.
  • the catheter 200 includes an outer tube 203, a dual balloon 234, and an inner tube 222.
  • the ability to place the guide catheter is a significant factor in the size of the device.
  • a suitably sized guide catheter may be used to perform angioplasty in the coronary arteries. This then restricts the size of the catheter 200 which may be disposed within the guide catheter.
  • a typical diameter of the catheter 200 may then be about 3 french or less or about 35-39 mils. The same may be placed in the femoral artery in order to be able to track to the coronary arteries in a known manner.
  • the outer tube 203 houses the catheter 200 and may have an outside diameter of about 5 french to 7 french, and the same may be made of similar materials.
  • the distal end of the outer tube 203 adjoins the proximal end of the dual balloon 234.
  • the outer tube 203 provides a mounting location for an outer balloon 204, and further provides an inlet 228 for providing a fluid such as a liquid to a first interior volume 206 between the dual balloons.
  • an inlet 228 per se may not be necessary: the fluid, which may also be a sub-atmospheric level of air, may be provided in the first interior volume 206.
  • the proximal and distal ends of the volume may be sealed during manufacture.
  • the inlet 228 may be at least partially defined by the annular volume between the interior of the outer tube 203 and the exterior of the inner tube 222.
  • the dual balloon 234 includes an outer balloon 204 and an inner balloon 208. These balloons are basically similar to balloons 104 and 108 described above, but may be made even smaller for use in the smaller coronary arteries.
  • the same types of fluids may be used as in the catheter 100.
  • the inner tube 222 is disposed within the interior of the dual balloon 234 and within the interior of the guide catheter 202.
  • the inner tube 222 includes a supply lumen 220 and a return lumen 218.
  • a set of radio opaque marker bands 212 may be disposed on the inner tube 222 for the same reasons disclosed above in connection with the marker bands 112.
  • the proximal portion of the outer balloon 204 is mounted on the outer tube 203 at its distal end.
  • the distal end of the outer balloon 204 is secured to the distal end of the catheter 200 and along the inner tube 222.
  • both the proximal and distal ends of the inner balloon 208 may be secured to the inner tube 222 to create a sealed second interior volume 210.
  • At least two skives 224 and 226 may be defined by the inner tube 222 and employed to allow the working fluid to exit into the second interior volume 210 and to exhaust the same from the second interior volume 210.
  • a plurality of tabs 219 may be employed to roughly or substantially center the inner tube 222 within the catheter 200 as in catheter 100. These tabs may have the same general geometry and design as tabs 119. Of course, they may also be appropriately smaller to accommodate the smaller dimensions of this coronary artery design.
  • the tabs 119 and 219 are particularly important in the catheters 100 and 200, as contact by the inner tube of the outer tube may also be associated with an undesired conductive heat transfer prior to the working fluid reaching the working region, thereby deleteriously increasing the temperature of the working fluid at the working region.
  • the method of use of the catheter 200 is generally the same as for the catheter 100.
  • Known techniques may be employed to place the catheter 200 into an affected coronary artery.
  • an external guidewire may be used with appropriate attachments to the catheter.
  • a catheter 300 which may be employed in PV ablation is detailed.
  • a dual balloon system 301 is shown; however, the balloons are not one within the other as in Fig. 1.
  • a warm balloon 302 is distal of a cold balloon 304.
  • Warm balloon 302 may be used to anchor the system 301 against movements, which may be particularly useful within a beating heart.
  • Cold balloon 304 may then be employed to cryo-ablate a circumferential lesion at the point where a pulmonary vein 306 enters the left atrium 308.
  • a working fluid may be introduced via an outlet port 308 and may be retrieved via an inlet port 310.
  • Ports 308 and 310 may be skived in known fashion into the catheter shaft lumens whose design is exemplified below.
  • the warm balloon 302 serves to anchor the system 301 in the pulmonary vein and left atrium.
  • the warm balloon 302 also serves to stop blood, which is traveling in the direction indicated by arrow 312, from freezing upon contact with the cold balloon 304. In this way, the warm balloon 302 acts as an insulator to cold balloon 304.
  • the warm balloon 302 may be served by only one skived port, or by two ports, such as an inlet port 314 and an outlet port 316, as shown in Fig. 3.
  • a separate lumen or lumens may be used to fill the warm balloon.
  • a valve mechanism may be used to fill the warm balloon using fluid from the cold balloon. In the case where only one port is used to fill the warm balloon, draining the same requires a slight vacuum or negative pressure to be placed on the lumen servicing the inlet/outlet port.
  • a benefit to the two lumen design is that the warm balloon may be inflated and deflated in a more expeditious manner.
  • Typical pressures within the warm balloon may be about 1-2 atm (10-30 psi) , and thus maintains a fairly low pressure.
  • An appropriate fluid will be biocompatible, and may be Galden fluid, D5W, and so on.
  • Typical pressures within the cold balloon may be about 5-7 atm, for example about 6 atm (e.g., at about 100 psi), and thus maintains a higher pressure.
  • An appropriate fluid may be Galden fluid, e.g., HT-55, D5W, and so on.
  • the volume of fluid required to fill the cold balloon may vary, but may be about 4-8 cc .
  • the cold balloon may be about 2 to 2 Vz cm long, and have a diameter of 1 to 2 Vz cm.
  • the warm balloon may be glued or otherwise attached to the cold balloon.
  • draining both balloons may simply entail closing either the return lumen or the supply lumen, and drawing a vacuum on the other. In this way, both the cold and warm balloons may be evacuated.
  • a standard medical "indeflator" may be used to pressurize and de- pressurize the various lumens and balloons.
  • Fig. 4 shows an embodiment of the arrangement of lumens within the catheter.
  • supply and return lumens for the cold balloon 304 are shown by lumens 318 and 320, respectively.
  • Supply and return lumens for the warm balloon 302 are shown by lumens 322 and 324, respectively, although as noted only one may be used as required by the dictates of the user.
  • a guidewire lumen 326 is also shown.
  • An alternative arrangement is shown in Fig. 5, where the corresponding lumens are shown by primes .
  • the overall catheter outer diameter may be about .130", e.g. about 10 french, including an insulation sleeve and guide discussed below.
  • the catheter shaft 303 itself may be about .110" and may be made of, e.g., polyethylene (PE) , and preferably a combination of a low density PE and a high density PE .
  • the inlet and outlet ports or inlet/outlet port of the warm balloon may be skived from the lumens 322 and 324.
  • the warm balloon 302 itself may be made of a sleeve 332 of silicone tubing of, e.g., 35 durometer on the "D" scale, and held in place by two pieces of PET heat shrink tubing 334.
  • Alternative methods of securing the warm balloon during inflation may include metal bands or an adhesive.
  • marker bands 336 may be employed within either or both of the cold balloon and warm balloon to assist the physician is disposing the same in an appropriate location.
  • the marker bands typically denote the working areas of the balloons, and may be made of Pt, Iridium, Au, etc.
  • the working cold fluid may exit the circulation system or chiller at, e.g., about -85°C.
  • the circulation system or chiller may be, e.g., a two-stage heat exchanger.
  • the fluid may then enter the catheter at about -70°C to about -75°C, and may strike the balloon at about -55°C to about -65°C.
  • the overall procedure may take less than a minute to circumferentially ablate the desired tissue up to several minutes.
  • these numbers are only exemplary and the same depend on the design of the system and fluids used.
  • Mapping electrodes 338 may be employed at the distal end of the warm balloon. These mapping electrodes may each have a wire attached, the wires extending down, e.g., the supply and return lumens for the warm fluid or the cold fluid. The mapping electrodes 338 may be used to detect stray electrical fields to determine where ablation may be needed and/or whether the ablation procedure was successful . The mapping electrodes may typically be about 2-3 mm apart from each other.
  • Construction of the warm balloon typically involves adhering the same to the shaft 303 and skiving the inlet and outlet ports.
  • the silicone sleeve 340 may then serve to further insulate the non-working sections of the balloons from blood that would otherwise potentially freeze during a procedure.
  • the silicone sleeve would typically be attached only at a portion of its length, such as that indicated by circle 342, so that the same may slide along the balloon as the balloon is inflated. In addition to insulation effects, the silicone sleeve also serves to assist in collapsing the balloon during deflation.
  • Either or both of the dual balloons may be doped to improve their thermal conductivities.
  • the shaft of inner tube 122 may be made of Pebax, PBT, Pl/PEI, PU, PA 11/12, SI, or other such materials.
  • the precise shapes and dimensions of the inner and outer lumens, while indicated in, e.g., Figs. IB, 1C, and 2B, may vary.
  • the lumen design shown in Figs. 1B-1C may be employed in the catheter of Fig. 2A and vice-versa.
  • Embodiments of the invention may be employed in the field of cold mapping, where a circle of tissue is cooled to see if the affected part has been reached. If the affected tissue is that which is being cooled, a more vigorous cooling may be instituted.
  • Other variations will be clear to one of skill in the art, thus the invention is limited only by the claims appended hereto.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

L'invention concerne un procédé et un dispositif améliorés destinés à inhiber ou réduire la vitesse de resténose post-angioplastie ou après la mise en place d'un extenseur. Il s'agit de mettre en place une sonde (100) à ballonnet dans la région traitée ou ouverte par le biais d'une angioplastie par ballonnet suivant immédiatement l'angioplastie. Le ballonnet, qui peut avoir une structure à deux ballonnets, peut être administré par le biais d'une sonde-guide (102) et sur un fil-guide déjà en place par une angioplastie par ballonnet. Un fluide, par exemple un perfluocarbone, peut s'écouler dans le ballonnet afin de geler le tissu jouxtant le ballonnet, ce refroidissement étant associé à la réduction de la resténose. La sonde peut également servir à réduire la fibrillation auriculaire par insertion et dilatation du ballonnet, la surface extérieure de ce dernier étant alors en contact au moins partiellement avec la périphérie de la partie de la veine pulmonaire jouxtant L'oreillette gauche.
EP01916337A 2000-03-01 2001-03-01 Therapies de refroidissement/dispositif pour angioplastie avec restenose Withdrawn EP1261304A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US516319 1983-07-22
US51631900A 2000-03-01 2000-03-01
PCT/US2001/006648 WO2001064145A1 (fr) 2000-03-01 2001-03-01 Therapies de refroidissement/dispositif pour angioplastie avec restenose

Publications (2)

Publication Number Publication Date
EP1261304A1 true EP1261304A1 (fr) 2002-12-04
EP1261304A4 EP1261304A4 (fr) 2005-06-08

Family

ID=24055036

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01916337A Withdrawn EP1261304A4 (fr) 2000-03-01 2001-03-01 Therapies de refroidissement/dispositif pour angioplastie avec restenose

Country Status (5)

Country Link
EP (1) EP1261304A4 (fr)
JP (1) JP2003524506A (fr)
AU (2) AU2001243374B2 (fr)
CA (1) CA2400753A1 (fr)
WO (1) WO2001064145A1 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5971979A (en) 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia
US6428534B1 (en) 1999-02-24 2002-08-06 Cryovascular Systems, Inc. Cryogenic angioplasty catheter
US6432102B2 (en) 1999-03-15 2002-08-13 Cryovascular Systems, Inc. Cryosurgical fluid supply
US6682473B1 (en) 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US10327880B2 (en) 2000-04-14 2019-06-25 Attenuex Technologies, Inc. Attenuation device for use in an anatomical structure
US7374532B2 (en) 2000-04-14 2008-05-20 Attenuex Technologies, Inc. High vapor pressure attenuation device
US8574146B2 (en) 2000-04-14 2013-11-05 Attenuex Technologies, Inc. Implant with high vapor pressure medium
US6955174B2 (en) 2000-08-18 2005-10-18 Uryovascular Systems, Inc. Cryotherapy method for detecting and treating vulnerable plaque
US6602246B1 (en) 2000-08-18 2003-08-05 Cryovascular Systems, Inc. Cryotherapy method for detecting and treating vulnerable plaque
US6786900B2 (en) 2001-08-13 2004-09-07 Cryovascular Systems, Inc. Cryotherapy methods for treating vessel dissections and side branch occlusion
US7758572B2 (en) * 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices and methods including cooling balloons having nanotubes
EP1940316B1 (fr) 2005-09-26 2015-10-21 AttenueX Technologies, Inc. Dispositif d'attenuation de pression
US8579889B2 (en) 2008-01-11 2013-11-12 Boston Scientific Scimed Inc. Linear ablation devices and methods of use
CA2703414A1 (fr) 2008-01-11 2009-07-16 Boston Scientific Scimed, Inc. Dispositifs d'ablation et procedes d'utilisation
JP5693471B2 (ja) 2009-02-11 2015-04-01 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 絶縁された切除カテーテルデバイスおよびその使用法
TWI517833B (zh) * 2009-03-31 2016-01-21 東麗股份有限公司 附有氣球之電燒導管用軸及附有氣球之電燒導管系統
WO2011008444A1 (fr) 2009-06-30 2011-01-20 Boston Scientific Scimed, Inc. Cathéter hybride irrigué ouvert de cartographie et d'ablation
EP2600784B1 (fr) 2010-08-05 2021-12-29 Medtronic Ireland Manufacturing Unlimited Company Appareils, systèmes et procédés de neuromodulation rénale par cryoablation
US20120143294A1 (en) 2010-10-26 2012-06-07 Medtronic Adrian Luxembourg S.a.r.l. Neuromodulation cryotherapeutic devices and associated systems and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
EP2632372A4 (fr) * 2010-10-27 2015-04-01 Cryomedix Llc Appareil de cryoablation avec zone d'échange de chaleur renforcé et procédé associé
US9089340B2 (en) 2010-12-30 2015-07-28 Boston Scientific Scimed, Inc. Ultrasound guided tissue ablation
EP2696821B1 (fr) 2011-04-13 2017-10-18 Cryotherapeutics GmbH Stabilisation de plaque à l'aide de cryoénergie
ITGE20110043A1 (it) * 2011-04-18 2012-10-19 Gian Battista Chierchia " dispositivo adattabilie per l'isolamento elettrico delle vene polmonari in fibrillazione atriale "
CN103930061B (zh) 2011-04-25 2016-09-14 美敦力阿迪安卢森堡有限责任公司 用于限制导管壁低温消融的有关低温球囊限制部署的装置及方法
JP2014516723A (ja) 2011-06-01 2014-07-17 ボストン サイエンティフィック サイムド，インコーポレイテッド 超音波映像性能を備えた切除プローブ
JP6117209B2 (ja) 2011-09-14 2017-04-19 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 複数のアブレーションモードを備えたアブレーション装置及び同アブレーション装置を含むシステム
US9603659B2 (en) 2011-09-14 2017-03-28 Boston Scientific Scimed Inc. Ablation device with ionically conductive balloon
JP2015506209A (ja) 2011-12-28 2015-03-02 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． アブレーションプローブならびにアブレーションおよび超音波撮像システム
WO2013106557A1 (fr) 2012-01-10 2013-07-18 Boston Scientific Scimed, Inc. Système d'électrophysiologie
US8945015B2 (en) 2012-01-31 2015-02-03 Koninklijke Philips N.V. Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging and treatment
US9241752B2 (en) 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods
EP2840991B1 (fr) 2012-04-27 2019-05-15 Medtronic Ardian Luxembourg S.à.r.l. Dispositifs cryothérapeutiques pour la neuromodulation rénale
US8894563B2 (en) 2012-08-10 2014-11-25 Attenuex Technologies, Inc. Methods and systems for performing a medical procedure
US9370329B2 (en) 2012-09-18 2016-06-21 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter
US9211156B2 (en) 2012-09-18 2015-12-15 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter with flat tip
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9017317B2 (en) 2012-12-06 2015-04-28 Medtronic Ardian Luxembourg S.A.R.L. Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods
US9931153B2 (en) * 2013-03-15 2018-04-03 Spiration, Inc. Thermochemical reaction ablation catheter
WO2015048806A2 (fr) 2013-09-30 2015-04-02 Nidus Medical, Llc Appareil et méthodes pour traiter la rhinite
US10492842B2 (en) 2014-03-07 2019-12-03 Medtronic Ardian Luxembourg S.A.R.L. Monitoring and controlling internally administered cryotherapy
JPWO2015141408A1 (ja) * 2014-03-19 2017-04-06 テルモ株式会社 医療器具
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
CN106793968A (zh) 2014-10-13 2017-05-31 波士顿科学医学有限公司 使用微电极的组织诊断和治疗
US10603105B2 (en) 2014-10-24 2020-03-31 Boston Scientific Scimed Inc Medical devices with a flexible electrode assembly coupled to an ablation tip
CN106999080B (zh) 2014-12-18 2020-08-18 波士顿科学医学有限公司 针对病变评估的实时形态分析
EP3413822B1 (fr) 2016-02-11 2023-08-30 Arrinex, Inc. Dispositif de post-ablation de nerf nasal guidée par une image
US11026738B2 (en) 2016-06-15 2021-06-08 Arrinex, Inc. Devices and methods for treating a lateral surface of a nasal cavity
US10939965B1 (en) 2016-07-20 2021-03-09 Arrinex, Inc. Devices and methods for treating a nerve of the nasal cavity using image guidance
US11253312B2 (en) 2016-10-17 2022-02-22 Arrinex, Inc. Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use
WO2018201158A1 (fr) 2017-04-28 2018-11-01 Arrinx, Inc. Systèmes et procédés de localisation de vaisseaux sanguins dans le traitement de la rhinite
US11806484B2 (en) 2018-01-19 2023-11-07 Focalcool, Llc Catheter with heat transfer minimizing annular space
WO2020163625A1 (fr) 2019-02-07 2020-08-13 Solace Therapeutics, Inc. Dispositif d'atténuation de pression
WO2024095824A1 (fr) * 2022-11-02 2024-05-10 株式会社カネカ Cathéter de cryo-ablation et système de cathéter de cryo-ablation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5868735A (en) * 1997-03-06 1999-02-09 Scimed Life Systems, Inc. Cryoplasty device and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5630837A (en) * 1993-07-01 1997-05-20 Boston Scientific Corporation Acoustic ablation
US5971979A (en) * 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5868735A (en) * 1997-03-06 1999-02-09 Scimed Life Systems, Inc. Cryoplasty device and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0164145A1 *

Also Published As

Publication number Publication date
CA2400753A1 (fr) 2001-09-07
EP1261304A4 (fr) 2005-06-08
AU2001243374B2 (en) 2005-02-03
JP2003524506A (ja) 2003-08-19
AU4337401A (en) 2001-09-12
WO2001064145A1 (fr) 2001-09-07

Similar Documents

Publication Publication Date Title
US6602276B2 (en) Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
AU2001243374B2 (en) Cooling therapies/device for angioplasty with restenosis
US7449018B2 (en) Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US8157794B2 (en) Method and device for performing cooling-or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
AU2001243374A1 (en) Cooling therapies/device for angioplasty with restenosis
US8043351B2 (en) Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US7001378B2 (en) Method and device for performing cooling or cryo-therapies, for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US20040220559A1 (en) Preparation of working fluid for use in cryotherapies
US6482226B1 (en) Selective organ hypothermia method and apparatus
US7063718B2 (en) Selective organ hypothermia method and apparatus
US20030014095A1 (en) Preparation of working fluid for use in cryotherapies
WO2003028524A2 (fr) Preparation d'un fluide actif utilise en cryotherapie
AU2004201679A1 (en) Selective organ hypothermia method and apparatus
AU769280B2 (en) Selective organ hypothermia method and apparatus
CA2470150A1 (fr) Procede et dispositif selectifs servant a mettre un organe en hypothermie

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021001

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050425

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050709